Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Oct 28;13(11):1479.
doi: 10.1093/ecco-jcc/jjz078.

Cannabinoid Signal Transduction Explains Disconnect of Cannabis Effects in Experimental and Clinical Colitis

Maikel P Peppelenbosch  1 , Kaushal Parikh  1 , Gwenny Fuhler  1
Affiliations
Comment

Cannabinoid Signal Transduction Explains Disconnect of Cannabis Effects in Experimental and Clinical Colitis

Maikel P Peppelenbosch et al. J Crohns Colitis. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Ambrose T, Simmons A. Cannabis, cannabinoids, and the endocannabinoid system—is there therapeutic potential for inflammatory bowel disease? J Crohns Colitis 2019;13:525–35. - PMC - PubMed
    1. Utomo WK, de Vries M, Braat H, et al. . Modulation of human peripheral blood mononuclear cell signaling by medicinal cannabinoids. Front Mol Neurosci 2017;10:14. - PMC - PubMed
    1. Schreiber S, Feagan B, D’Haens G, et al. ; BIRB 796 Study Group Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn’s disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006;4:325–34. - PubMed
    1. Shi G, Li D, Ren J, et al. . mTOR inhibitor INK128 attenuates dextran sodium sulfate-induced colitis by promotion of MDSCs on Treg cell expansion. J Cell Physiol 2019;234:1618–29. - PubMed
    1. Reinisch W, Panés J, Lémann M, et al. . A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn’s disease. Am J Gastroenterol 2008;103:2284–92. - PubMed